Angiostatin inhibition of vascular endothelial growth factor-stimulated nitric oxide production in endothelial cells

Journal of Pharmacological Sciences

Volumn 112, Issue 4, 2010, Pages 432-437

  Takahashi, Satoru ^a   Shinya, Tomohiro ^a   Sugiyama, Akinori ^a,b  

^a KYUSHU UNIVERSITY OF HEALTH AND WELFARE   (Japan)

^b IWATE MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiostatin; Endothelial nitric oxide synthase (eNOS); Nitric oxide (NO); Phosphorylation; Vascular endothelial growth factor (VEGF)

Indexed keywords

ANGIOSTATIN; CALCIUM CHANNEL; CALCIUM ION; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; SERINE; VASCULOTROPIN;

ANTIANGIOGENIC ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; DISULFIDE BOND; DRUG EFFECT; ENDOTHELIUM CELL; ENZYME ACTIVATION; HUMAN; HUMAN CELL; KRINGLE DOMAIN; PROTEIN PHOSPHORYLATION;

EID: 77951228599     PISSN: 13478613     EISSN: 13478648     Source Type: Journal    
DOI: 10.1254/jphs.10028FP     Document Type: Article

References (26)

1. Folkman J. Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat Med. 1995;1:27-31.
2. Folkman J. Angiogenesis: an organizing principle for drug discovery? Nat Rev. 2007;6:273-286.
3. O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, et al. Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell. 1994;79:315-328.
4. O'Reilly MS, Holmgren L, Chen L, Chen C, Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med. 1996;2:689-692.
5. Troyanovsky B, Levchenko T, Månsson G, Matvijenko O, Holmgren L. Angiomotin: an angiostatin binding protein that regulates endothelial cell migration and tube formation. J Cell Biol. 2001;152:1247-1254.
6. Eriksson K, Magnusson P, Dixelius J, Claesson-Welsh L, Cross MJ. Angiostatin and endostatin inhibit endothelial cell migration in response to FGF and VEGF without interfering with specific intracellular signal transduction pathways. FEBS Lett. 2003; 536:19-24.
7. Holmgren L, O'Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med. 1995;1:149-153.
8. Claesson-Welsh L, Welsh M, Ito N, Anand-Apte B, Soker S, Zetter B, et al. Angiostatin induces endothelial cell apoptosis and activation of focal adhesion kinase independently of the integrin-binding motif RDG. Proc Natl Acad Sci U S A. 1998;95:5579-5583.
9. Koshida R, Ou J, Matsunaga T, Chilian WM, Oldham KT, Ackerman AW, et al. Angiostatin a negative regulator of endothelial-dependent vasodilation. Circulation. 2003;107:803-806.
10. 2+ signaling in endothelial cells by the angiogenesis inhibitors endostatin and angiostatin. Am J Physiol. 2001;280:C1140-C1150.
11. Shojaei F, Ferrara N. Antiangiogenesis to treat cancer and intraocular neovascular disorders. Lab Invest. 2007;87:227-230.
12. Fukumura D, Gohongi T, Kabambi A, Izumi Y, Ang J, Yun CO, et al. Predominant role of endothelial nitric oxide synthase in vascular endothelial growth factor-induced angiogenesis and vascular permeability. Proc Natl Acad Sci U S A. 2001;98:2604-2609.
13. Ku DD, Zaleski JK, Liu S, Brock TA. Vascular endothelial growth factor induces EDRF-dependent relaxation in coronary arteries. Am J Physiol. 1993;265:H586-H592.
14. Morbidelli L, Change C-H, Douglas JG, Granger HJ, Ledda F, Ziche M. Nitric oxide mediates the mitogenic effect of VEGF on coronary venular endothelium. Am J Physiol. 1996;270:H411-H415.
15. Ziche M, Morbidelli L, Choudhuri R, Zhang H-T, Donnini S, Granger HJ, et al. Nitric oxide synthase lies downstream from vascular endothelial growth factor-induced but not basic fibro-blast growth factor-induced angiogenesis. J Clin Invest. 1997;99: 2625-2634.
16. Papapetropoulos A, Garcia-Cardeña G, Madri JA, Sessa WC. Nitric oxide production contributes to the angiogenic properties of vascular endothelial growth factor in human endothelial cells. J Clin Invest. 1997;100:3131-3139.
17. Takahashi S, Uchiyama T, Toda K. Differential effect of resveratrol on nitric oxide production in endothelial F-2 cells. Biol Pharm Bull. 2009;32:1840-1843.
18. Takahashi S, Nakashima Y, Toda K. Carnosine facilitates nitric oxide production in endothelial F-2 cells. Biol Pharm Bull. 2009;32:1836-1839.
19. Takahashi S, Mendelsohn ME. Synergistic activation of endothelial nitric-oxide synthase (eNOS) by HSP90 and Akt. J Biol Chem. 2003;278:30821-30827.
20. Ji WR, Castellino FJ, Chang Y, Deford ME, Gray H, Villarreal X, et al. Characterization of kringle domains of angiostatin as antagonists of endothelial cell migration, an important process in angiogenesis. FASEB J. 1998;12:1731-1738.
21. Cao Y, Ji RW, Davidson D, Schaller J, Marti D, Söhndel S, et al. Kringle domains of human angiostatin. J Biol Chem. 1996;271: 29461-29467.
22. Fulton D, Gratton J-P, McCabe TJ, Fontana J, Fujio Y, Walsh K, et al. Regulation of endothelium-derived nitric oxide production by the protein kinase Akt. Nature. 1999;399:597-601.
23. Dimmeler S, Fleming I, Fisslthaler B, Hermann C, Busse R, Zeiher AM. Activation of nitric oxide synthase in endothelial cells by Akt-dependent phosphorylation. Nature. 1999;399:601-605.
24. Dimmeler S, Dernbach E, Zeiher AM. Phosphorylation of the endothelial nitric oxide synthase at ser-1177 is required for VEGF-induced endothelial cell migration. FEBS Lett. 2000;477: 258-262.
25. 2+-dependent to the late phosphorylation-dependent activation of the endothelial nitric-oxide synthase in vascular endothelial growth factor-exposed endothelial cells. J Biol Chem. 2001;276:32663-32669.
26. Dudzinski DM, Michel T. Life history of eNOS: partners and pathways. Cardiovasc Res. 2007;75:247-260.